Assessing the Safety of Inhaled Zanamivir Exposure in Pregnant Women
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2014
At a glance
- Drugs Zanamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 18 Apr 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 22 Feb 2013 Planned number of patients 1 added as reported by ClinicalTrials.gov.
- 02 Nov 2011 New trial record